
AI-powered screening solutions that improve access to diabetic retinopathy detection and enable cost-effective eye screenings anywhere.
Contact us
Portability without compromising image quality
Our new flagship product, Optomed Lumo, enables fast and effective eye screenings for more patients. Imaging is made simple with intuitive user guidance, automated imaging functions, and a touch screen interface. Eye screenings with Optomed Lumo can be integrated into various workflows, and the device adapts to different healthcare environments in both handheld and desktop forms.
The handheld Optomed Aurora IQ enables high-quality retinal imaging for diabetic retinopathy (DR) screening providers. The Aurora AEYE is the first FDA-cleared handheld fundus camera for autonomous diabetic retinopathy detection in the United States.
Clinical studies show that the Optomed Aurora with patented optical design achieves sensitivity and specificity on par with conventional tabletop cameras for diabetic retinopathy screening.
Instant detection of diabetic retinopathy with AI
Optomed’s handheld cameras—Optomed Lumo and Optomed Aurora IQ—feature integrated AI connectivity, enabling cost-effective eye screenings anywhere.
Screening results are delivered instantly on the camera display and can be shared with the patient on- the-spot. Detailed AI reports are also available through the Optomed Portal.

Automatization of large-scale screening processes
Avenue Eye Screen is a comprehensive workflow management system that automates the screening and follow-up of eye diseases, such as diabetic retinopathy, while ensuring seamless information flow across the entire screening process
Making Diabetic Retinopathy Screening Accessible
The number of people with diabetes has been growing rapidly around the world and one third of them suffer from diabetic retinopathy, the most common cause of vision loss in working-age adults.
Diabetic retinopathy is treatable, if detected early. Despite the increasing importance of early detection, eye screening is still not reaching the people who need it most. Worldwide, millions remain undiagnosed for preventable or manageable eye conditions—simply due to lack of access.
Optomed’s high-quality and effective eye screening solution with handheld cameras and automatization of screening process can break down the barriers and make screening more accessible, scalable and impactful than ever before.

Contact us